Two Sigma Investments’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $270K | Sell |
19,300
-83,103
| -81% | -$1.16M | ﹤0.01% | 2781 |
|
|
2025
Q1 | $1.39M | Sell |
102,403
-77,481
| -43% | -$1.05M | ﹤0.01% | 1926 |
|
|
2024
Q4 | $3.67M | Buy |
179,884
+80,417
| +81% | +$1.64M | 0.01% | 1243 |
|
|
2024
Q3 | $2.9M | Buy |
99,467
+4,600
| +5% | +$134K | 0.01% | 1385 |
|
|
2024
Q2 | $2.2M | Sell |
94,867
-96,638
| -50% | -$2.24M | 0.01% | 1428 |
|
|
2024
Q1 | $3.93M | Buy |
191,505
+163,129
| +575% | +$3.35M | 0.01% | 1053 |
|
|
2023
Q4 | $609K | Buy |
+28,376
| New | +$609K | ﹤0.01% | 2278 |
|
|
2023
Q3 | – | Sell |
-34,400
| Closed | -$1.02M | – | 2929 |
|
|
2023
Q2 | $1.02M | Sell |
34,400
-41,341
| -55% | -$1.22M | ﹤0.01% | 1866 |
|
|
2023
Q1 | $1.75M | Buy |
75,741
+1,306
| +2% | +$30.1K | 0.01% | 1405 |
|
|
2022
Q4 | $2.07M | Sell |
74,435
-186,735
| -71% | -$5.19M | 0.01% | 1258 |
|
|
2022
Q3 | $8.02M | Buy |
261,170
+196,846
| +306% | +$6.04M | 0.03% | 549 |
|
|
2022
Q2 | $1.89M | Buy |
64,324
+34,323
| +114% | +$1.01M | 0.01% | 1189 |
|
|
2022
Q1 | $965K | Buy |
30,001
+21,425
| +250% | +$689K | ﹤0.01% | 1678 |
|
|
2021
Q4 | $382K | Sell |
8,576
-105,095
| -92% | -$4.68M | ﹤0.01% | 2086 |
|
|
2021
Q3 | $5.74M | Sell |
113,671
-105,744
| -48% | -$5.34M | 0.01% | 838 |
|
|
2021
Q2 | $17.2M | Sell |
219,415
-277,288
| -56% | -$21.8M | 0.04% | 467 |
|
|
2021
Q1 | $28.4M | Buy |
496,703
+235,633
| +90% | +$13.5M | 0.07% | 281 |
|
|
2020
Q4 | $21.9M | Buy |
261,070
+70,025
| +37% | +$5.87M | 0.06% | 301 |
|
|
2020
Q3 | $6.85M | Buy |
191,045
+65,507
| +52% | +$2.35M | 0.02% | 523 |
|
|
2020
Q2 | $3.04M | Buy |
+125,538
| New | +$3.04M | 0.02% | 735 |
|